149 related articles for article (PubMed ID: 28849027)
1. Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach.
Meng H; Zhu X; Li L; Liang Z; Li X; Pan X; Zeng F; Qu S
Int J Mol Med; 2017 Oct; 40(4):1152-1164. PubMed ID: 28849027
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of succinate dehydrogenase subunit B and up-regulation of pyruvate dehydrogenase kinase 1 predicts poor prognosis in recurrent nasopharyngeal carcinoma.
Dai Z; Pan S; Chen C; Cao L; Li X; Chen X; Su X; Lin S
Tumour Biol; 2016 Apr; 37(4):5145-52. PubMed ID: 26547584
[TBL] [Abstract][Full Text] [Related]
3. Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma.
Xu T; Su B; Wang C; Wang S; Huang H; Pan Y; Wang D; Wei W; Claret FX; Yang H
Oncol Rep; 2015 Mar; 33(3):1418-26. PubMed ID: 25607111
[TBL] [Abstract][Full Text] [Related]
4. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
5. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
[TBL] [Abstract][Full Text] [Related]
7. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
[TBL] [Abstract][Full Text] [Related]
8. AGR2 diagnostic value in nasopharyngeal carcinoma prognosis.
Li Y; Wang W; Liu Z; Jiang Y; Lu J; Xie H; Tang F
Clin Chim Acta; 2018 Sep; 484():323-327. PubMed ID: 29269202
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma.
Lin SJ; Chang KP; Hsu CW; Chi LM; Chien KY; Liang Y; Tsai MH; Lin YT; Yu JS
J Proteomics; 2013 Dec; 94():186-201. PubMed ID: 24080422
[TBL] [Abstract][Full Text] [Related]
10. [Identification of differentially expressed genes in recurrent nasopharyngeal carcinoma and analysis of their chromosomal location].
Huang ZX; Li WF; Lin S; Huang Y; DU JM; Tan YX; Fang XB; Zhang CH; Fang WQ; Liao ZS
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jan; 45(1):47-51. PubMed ID: 20398539
[TBL] [Abstract][Full Text] [Related]
11. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
12. Regulatory role of CDX2 and NOX4 expression associated with recurrent nasopharyngeal carcinoma.
Chen G; Hao H; Ai JW
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):450-455. PubMed ID: 29424902
[TBL] [Abstract][Full Text] [Related]
13. Amyloid Beta (A4) Precursor Protein: A Potential Biomarker for Recurrent Nasopharyngeal Carcinoma.
Li XY; Meng HL; Li KG; Yang XH; Zhu XD; Li L; Liang ZG; Pan XB; Zeng FY; Qu S
Cancer Manag Res; 2019; 11():10651-10656. PubMed ID: 31908537
[TBL] [Abstract][Full Text] [Related]
14. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
15. [A pilot investigation on serum protein fingerprinting of nasopharyngeal carcinoma].
Huang XW; Zhou W; Chen J; Chu HQ; Xiao CW; Hua XY; Zhang P; Li HQ; Cui YH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):509-12. PubMed ID: 21924105
[TBL] [Abstract][Full Text] [Related]
16. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
17. Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma.
You R; Liu YP; Lin DC; Li Q; Yu T; Zou X; Lin M; Zhang XL; He GP; Yang Q; Zhang YN; Xie YL; Jiang R; Wu CY; Zhang C; Cui C; Wang JQ; Wang Y; Zhuang AH; Guo GF; Hua YJ; Sun R; Yun JP; Zuo ZX; Liu ZX; Zhu XF; Kang TB; Qian CN; Mai HQ; Sun Y; Zeng MS; Feng L; Zeng YX; Chen MY
Cancer Res; 2019 Dec; 79(23):5930-5943. PubMed ID: 31484669
[TBL] [Abstract][Full Text] [Related]
18. [Significance of dynamic enhanced MRI in differential diagnosis of radiofibrosis and recurrent nasopharyngeal carcinoma at the basilar clivus].
Zhong JL; Liang BL; Ding ZX; Shen J; Huang SQ; Ye RX; Xie BK; Sun Y
Ai Zheng; 2006 Jan; 25(1):105-9. PubMed ID: 16405762
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis.
Chang KP; Wu CC; Chen HC; Chen SJ; Peng PH; Tsang NM; Lee LY; Liu SC; Liang Y; Lee YS; Hao SP; Chang YS; Yu JS
Proteomics; 2010 Jul; 10(14):2644-60. PubMed ID: 20461718
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling.
Cho WC; Yip TT; Yip C; Yip V; Thulasiraman V; Ngan RK; Yip TT; Lau WH; Au JS; Law SC; Cheng WW; Ma VW; Lim CK
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):43-52. PubMed ID: 14734450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
